ð±å€ç°çš®ïŒEG.5ãå¢å äžïŒBA.2.86äºç³»çµ±ã â 2023幎09æ08æ¥ 19:17
å€ç°çš®ïŒEG.5ãå¢å äžïŒBA.2.86äºç³»çµ±ã
ïŒå€ç°æ ªã«ã€ããŠïŒ
https://www.hokeniryo.metro.tokyo.lg.jp/kansen/corona_portal/henikabu/screening.html
ïŒã²ãã è§£æçµæã®æšç§»ïŒé±å¥ïŒ
ïŒä»€åïŒå¹ŽïŒæïŒæ¥ïŒïŒææç¹ïŒïŒ
https://www.hokeniryo.metro.tokyo.lg.jp/kansen/corona_portal/henikabu/screening.files/genomu0509071.pdf
ã°ã©ããèŠããšãEG.5ãå¢å åŸåãªããšãåããã
XBB.1.6ã眮ãæãã€ã€ããããã«ãèŠããããäœãšãèšããªãã
äž¡è ãåããããšéåæ°ãªç¶æ³ãç¶ããŠããã
ãã®ä»ãXBBäºç³»çµ±ã®å²åã«å€§ããªå€åã¯ãªããæ³šç®ãããŠããBA.2.86ã¯ãçµ±èšã«ã¯ãŸã ä¹ã£ãŠããªãïŒïŒäŸãæ€åºãããã°ããïŒã
éçåçãå°ãããšããããšã¯ãå»çè³æºãå§è¿«ããããšãªããéãããæ²»çäœå¶ã§åãã§è¡ããããšãæå³ããã
æµè¡ã®å¢å çã«ã€ããŠãåãã ã
æ°åã³ããã¯ãä»ã§ã¯ã»ãšãã©ã®å Žåãæ²»çå¯èœãªç æ°ã ãããªã
ããã§ãé«éœ¢è ãªã©ã¯éçåããããæ»ã«è³ãç ã§ããããšã«å€ããã¯ãªãã
眹æ£ããã«æžãã°äœããã ããã¯ã¯ãã³ãã£ãŠéçåãé²ãããªããã€ã®ãããã«æ±ºãŸã£ãŠããã
ãã¡ã€ã¶ãŒãã»ã»ã»ã
æéã®ïŒåç®æ¥çš®ãéžæãããã ããïŒïŒæïŒæ¥ããã®ã¢ãã«ãã§ãè¯ãã£ããããªïŒãããããå¯åå¿ã¯ããã€ïŒïŒã
ãã®éããã€ãã³ã°ãïŒã€ã»ã©ã€ã¶ããŠããïŒããŒããä¹ ã ã®ããã«ã¿ã³ã¯ã ã£ãã®ã«ã»ã»ã»ïŒã
å¯ãåé¿ãã芳ç¹ããããã£ã³ã絡ã¿ã®ã€ãã³ãããã¹ããã
ã¡ãã·ã³è¡ãã®ããã®ãã¬ãŒãã³ã°ã«çµã£ãŠãå¿ èŠæå°éã®è¡åãããšããªãã
ïŒïŒæã«å ¥ãã°ãçš²åå宿ïŒãã¶ãäžäººïŒãåéããã
蹎ã£ãŠè¹Žã£ãŠè¹ŽããŸãããæŽããŠæŽããŠæŽããŸããã
èªåã®æè¶³ã®å»¶é·ãšããŠãç¡æèã«åšæãæ±ããããã«ãªããŸã§ç¹°ãè¿ãè¡ãã
座åŠã®äºç¿ãããŠãããªããšãªïŒãŸã ååããèªãã§ãªãïŒã
æµ®æ²åã¯ãå³å¯ã«ã¯çåŸãããªããã©ãåãããã«åå ããã
ãã¡ã³ãã€ãå Œãã¬ãŒãã³ã°ãã€ãå Œè¬ç¿ååè¬ã ã
ãŸãããã
ã¡ãã·ã³ã§ããã®ãšãäœãæµè¡ããŠãããã¯åãããªãã
ãã©ã€ãã«ã«ã«ã¡ã³ã¯ãç±³åœã®è£åºã¿ãããªããã ãããªã
ç±³åœã§æµè¡ããŠããå€ç°çš®ãããã®ãŸãŸèå»¶ããŠãããã ããã
ãã¡ãããæ è¡è ã¯èª°ããã¹ã¯ãªããŠããŠããªããã
ããããã»ã»ã»ã
ïŒå¹Žåã®æ©ç§ããªãã¯ãã³æµè¡åå€ããŸãã«åœåãããïŒïŒæïŒïŒæ¥ã«ãæµ®æ²åã¯æç°ããåã®ã¡ãã·ã³è¡ãã®äŸ¿ã«ä¹ã£ãïŒANAã®ã¡ãã·ã³ã·ãã£ãŒè¡ãïŒã
ã¡ãã·ã³è¡ããšãæ°ããªå€ç°çš®ã®ç»å Žãšã®æªããé¢ä¿ã»ã»ã»ã
ä»ãæ¥çã§æ³šç®ãéããŠããBA.2.86ã¯ããªãã¯ãã³åæ§ãå€ãã®å€ç°ãéããŠãéãã«æµè¡ã®ã¿ã€ãã³ã°ãèšããªããæœäŒããŠããã
ã¢ã«ãã¡ã®æµè¡ã®éããå€ãã®å€ç°ãèç©ãããŠãããšããã
äžè¬ã«ãé«ç åæ§ã®ãŠã€ã«ã¹ã¯ãåºãæµè¡ããããšã¯å°ãªãã
ã ã£ãŠãå®¿äž»ãæ»ãããŸã£ããå ãåããªããããªã
äžæãå ±åããããã«ã¯ããããŸã¬ã³ã¬ã³å¢æ®ãããã宿䞻ã®è³æºãé£ãã€ã¶ãããããã«ã倧人ããããŠããã®ãæå©ãšããããŠããã
ããããïŒïŒïŒïŒå¹Žã«è¥¿ã¢ããªã«ã§æµè¡ãããšãã©ã¯ãé«ç åæ§ã®ææçãèªç©ºæ©ã«ãã£ãŠãå šäžçã«åºãããªã¹ã¯ãæããã«ããïŒèŽæ»çã¯ïŒïŒããŒã»ã³ãè¶ ïŒã
çŸåšããã®ãªã¹ã¯ã¯ããã«é«ãŸã£ãŠããã
æ°åã³ãããæªæ¥æ°žå«ãé«ç åæ§ã«å€ç°ããããšã¯ãªããšããäžãäžãããªã£ãŠããå®¿äž»ã®æ»äº¡ãªã©ã§æµè¡ãæå¶ãããããå¿é ã«ã¯åã°ãªããªã©ãšããããšã¯ã誰ã«ãèšããªãã
ããã®å ç«ãåé¿ããèœåãç ãæŸãŸããæ°ããªæµè¡ã®ãã£ã³ã¹ããããã£ãŠããã
ãã¡ããããŠã€ã«ã¹ã«ãããªæŠç¥ã¯ãªãã
人é¡ãšåãã ãããã®å°äžã§é²åãç¶ããçç©ãšããŠïŒçç©ãªã®ããïŒïŒå ±åããŠããã ãã ã
å€ç°ãããæ°åã³ãããŠã€ã«ã¹ã®ç骚é ã ã
ãã®å€ç°ã®ããŒã¹ãææé床ã墿®èœåãç åæ§ããšãã»ãšãã»ããçŸä»£ã®äººé¡ã®ç掻æ§åŒïŒéœåžç掻è ã®å¢å ãèªç©ºæ©ç§»åãå«ãïŒã«ãŽã£ãããšãããããçµæããäžççãªå€§æµè¡ãçãã
æµ®æ²åçã«ã¯ãç¡çåæ§ãã£ãªã¢ããã®ææå²åã®å€ããæ°ã«ãªããšããã ã
ã¯ãç·æ¥äºæ 宣èšãè§£é€ããããèŠæãè§£ããããã§ã¯ãªãã
åœç«ææçç ç©¶æããBA.2.86系統ã«ã€ããŠæ¬æ¥ã¬ããŒãããªãªãŒã¹ããŠããã
ïŒæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã®å€ç°æ ª BA.2.86系統ã«ã€ããŠïŒ
https://www.niid.go.jp/niid/ja/2019-ncov/2551-cepr/12240-sars-cov-2-ba-2-86.html
ã2023幎9æ7æ¥ãŸã§ã«67ä»¶(ã€ã¹ã©ãšã«3ä»¶ããã³ããŒã¯12ä»¶ãç±³åœ7ä»¶ãè±åœ8ä»¶ãåã¢ããªã«16ä»¶ããã«ãã¬ã«2ä»¶ãã¹ãŠã§ãŒãã³5ä»¶ãã«ãã2ä»¶ããã©ã³ã¹6ä»¶ãã¹ãã€ã³3ä»¶ããªãŒã¹ãã©ãªã¢1ä»¶ãéåœ1ä»¶ãæ¥æ¬1ä»¶)ã®æ£è ããåé¢ã
ãåœå ã§ã¯9æ7æ¥ã«æ±äº¬éœããGISAIDã«ç»é²ãããBA.2.86.1系統1ä»¶ã®ã¿ã確èªãããŠãããæ±äº¬éœããå ±åããã1ä»¶ã«ã€ããŠã¯ã8æ24æ¥ã«éœå å»çæ©é¢ã§æ¡åãããæ€äœã§ããããšãå ¬è¡šãããŠããã
ãBA.2.86系統ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«BA.2ç³»çµ±ãšæ¯èŒããŠ30以äžãXBB.1.5ç³»çµ±ãšæ¯èŒããŠ35以äžã®ã¢ããé žã®éããããããšãããã¯ã¯ãã³ãææã«ããäžåæäœã«ããå ç«ããéé¿ããå¯èœæ§ãçããŠãããã
ãçŸæç¹ã§ãéç床ã®å€åãæææ§ã«é¢ããç«åŠçãèšåºçç¥èŠã¯ãªããã
ãæ€æ»ãžã®åœ±é¿ã«é¢ããŠãåœç«ææçç ç©¶æã§ã¯BA.2.86系統ã®ã²ãã è§£æçµæããææç PCRæ³ã«ããããã©ã€ããŒããããŒãé åã«å€ç°ããªãããšã確èªããŠããã
ãç§ä»¥éã«æ¥çš®ã宿œãããXBB.1.5系統察å¿ïŒäŸ¡ã¯ã¯ãã³ãçç£ã販売ããŠãããã¡ã€ã¶ãŒç€Ÿãã¢ãã«ã瀟ã¯ããããçŸåšæºåäžã®ã¯ã¯ãã³ã«ãããŠãBA.2.86系統ã«å¯Ÿããäžå掻æ§ã確èªããã
ãCDCã¯è€æ°ã®ç±³åœæ¿åºæ©é¢ã®å°éå®¶ã§æ§æãããSARS-CoV-2 Interagency Group (SIG)ã®æèŠãšããŠã BA.2.86ç³»çµ±ã®æããã¢ããé žå€ç°ããã¯ããã«ããã¬ã«ãã«ã»ãªãããã«ãã¬ã ãã·ãã«ãã¢ã«ããã©ãã«ãªã©ã®çŸåšäœ¿çšå¯èœãªCOVID-19ã«å¯ŸããæãŠã€ã«ã¹è¬ã¯BA.2.86系統ã«å¯ŸããŠãæå¹æ§ã瀺åããããšããŠããã
ããŒããä»ã®ãšãããå ·äœã«å€§éšãããªããã°ãªããªãç¶æ³ã«ã¯ãªãããã ãªã
ãæ€åºæ°ã¯å°ãªããã®ã®ãæ¢åã®å€ç°æ ªãšæ¯èŒããã¢ããé žã®éããå€ãããšãããWHOã¯8æ17æ¥ã«ã欧å·çŸç äºé²ç®¡çã»ã³ã¿ãŒ(ECDC)ã¯8æ24æ¥ã«BA.2.86系統ãç£èŠäžã®å€ç°æ ª(VUMïŒVariants Under Monitoring)ã«æå®ããã
ããã€ã倧åããããšãã䌌ããããªã®ãåºãŠããŠæµè¡ãå éãããããªããšã«ãªãã°ãå šäžççã«ææå¯ŸçãæŸæ£ããŠããçŸç¶ã¯ããŠã€ã«ã¹ã«ãšã£ãŠã¯å€©åœãã®ãã®ã ãããªã
ãã£ãšããéã«åºããã ããã
ãŸããåºãã£ãŠãåãããªããšããããšãããïŒæ€æ»ããŠãªããïŒã
ãã¡ãããæµè¡ããªãæ¹ãããããç åæ§ãäžãããªãæ¹ãããã«æ±ºãŸã£ãŠããã
æµ®æ²åã¯ãé«éœ¢è ã§æç æã¡ã ã
ãã€ãã³ã°ãªã©ãšãããããã§ãªããŠããªã¹ããŒãªè¶£å³ãæã¡ããããç¶ããããã«ãææã®ãªã¹ã¯ãé«ããã£ãããã¹ã«éã£ãŠããïŒä»æ¥ã¯å°é¢šã§ãµãããŸãããïŒã
åšå²ã¯ãææçµéšè ã ããã«ãªã£ãŠãããããã€çœ¹æ£ããŠãããããã¯ãªãã
æ°åã³ããã«é¢ããŠãäœãç¥èãåŸããããšãã£ãŠãè¡åã«å€§ããªå€åãäžããããšã¯ãªãã
è³ãçºéãããåç©ãšããŠã¯å€±æ Œã ãªã
ãªã¹ã¯ãåé¿ããçå確çãäžããè¡åã«ç¹ãããªããã°ãç²åŸããæ å ±ãæå¹ã«æŽ»çšããŠãããšã¯èšããªãã
ãã€ãã®ããã«çé£ãããã€ãã®ããã«çç¡ããã
çµæããªããŠã³ãããŠéããªããæ ãŠãŠå·æ¿ã®å¹ãããã£ãããã¹ã§éåããŠæ±ãããïŒççŸããŠãïŒïŒã
ãŸããã©ãã§ããããã§ããã
ã¯ã¯ãã³æ¥çš®ã®æ¥çšãåªå ãããŠãããã«ã¿ã³ã¯ã®ãã¬ãŒãã³ã°ãã€ãããã¹ããããšãšãå¯åé¿ãçç±ã«é«æãã€ãã³ã°ããã¹ããçšåºŠã ã
ãã£ãããã¹ãããŒãã®ãã«ãŠã³ãããŠããããããããªãïŒãããªãïŒïŒã
確èªããŠãããã
æ±äº¬éœã®ç¬¬ïŒæ³¢ã¯ããŒã¯ã¢ãŠãããæµè¡äžã®å€ç°çš®ã¯EG.5系統ãå¢å ããŠããã
æ¬æ¥çŸåšãå šåœã®ïŒïŒæ³ä»¥äžã®æšå®ææè æ°ã®å¢å ã¯ç¶ããŠããã
ãŠã¯ã©ã€ãçŽäºã¯ç¶ããŠããããäžçã¯æŠã宿³°ã ã
æ°åã³ããã§ã¯ãïŒå¹Žäœãã®éã«ãå šäžçã§æ°çŸäžäººãæ»ãããŸã£ããããŠã¯ã©ã€ãã§ã¯ãïŒå¹Žåã§ããããæ°åäžäººã®æ»å·è ã ã
人é¡ãæã殺ããŠããã®ãç«ç ã§ããããšã¯å€ãããªãã
æã ã¯ãããã宿åœãšããŠåãå ¥ããããåŸãªãã
æ°åã³ããã§éãã€ããéã£ãŠããïŒã
ãžãžããäžå¿ã®éçåãªããã ãããäžéã®é¢å¿ã¯äœãã
瀟äŒäžå®ã®å¿é ã¯æ¶ããã
ããããã¯äžæã®è©±ã ããããããªãã
äžå¯žå ã¯éã®æ°åã³ããã
ãã®æªæ¥ãç §ããããã³ããã«ãã©ã€ãã¯ãã©ãã«ã売ã£ãŠããªãã®ã ã»ã»ã»ã
ïŒä»¥äžè¿œå ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒã³ããæ»è å¢å ã®ç±³åœã次æã¯ã¯ãã³ã8æ¥ã«ãæ¿èªãžïŒ
https://forbesjapan.com/articles/detail/65859
ç±³åœã®ææç¶æ³ãã¬ããŒãããèšäºãäžãã£ãŠããã®ã§ãªã³ã¯ããŠããã
ãæ¬¡æã¯ã¯ãã³ã¯ãç±³åœã§ã¯åããŠæ¥çš®ãç¡æåãããªãã³ããã¯ã¯ãã³ãšãªãããã¡ã€ã¶ãŒãšã¢ãã«ãã®äž¡ç€Ÿã¯ãæ°ã¯ã¯ãã³ã®æ¥çš®è²»çšã1å110ïœ130ãã«ïŒçŽ1äž6000ïœ1äž9000åïŒãšèŠç©ãã£ãŠããããã ããä¿éºäŒç€Ÿã®å€ããæ¥çš®è²»çšãè² æ ããèŠèŸŒã¿ã§ãç¡ä¿éºè ã«å¯ŸããŠã¯CDCãè²»çšãè² æ ããããã°ã©ã ãä»ç§éå§ãããã
ç±³åœã§ã¯ãæ¢ã«ã¯ã¯ãã³ã¯ææåã ã
éã®åãç®ãåœã®åãç®ã»ã»ã»ã
ãã³ããé¢é£ã®æ»è ãšå ¥é¢ã¯åå€ããå¢å ããŠãããç§ããå¬ã«ãããŠãå¢å ãããšäºæ³ãããŠãããCDCã®ææ°ããŒã¿ã«ãããšãæ»è ã¯7æ8æ¥ïœ8æ26æ¥ã«çŽ18ïŒ å¢å ããå ¥é¢ã¯7æ28æ¥ãã8æ26æ¥ã®éã«çŽ16ïŒ å¢å ãããã
æãåœã§ã¯ãæ»è æ°ã®çµ±èšãæŸæ£ãããããªïŒæããã«ãªãã®ã¯ãïŒãæåŸã ïŒã
ãç±³åœã§çŸåšäž»æµãšãªã£ãŠããã®ã¯ãXBB系統ã®1ã€ã§ãããEG.5ãïŒéç§°ãšãªã¹ïŒã§ã8æ20æ¥ïœ9æ2æ¥ã®å šçäŸã®çŽ22ïŒ ãå ããŠãããFDAã«ãããšãXBB系統ã¯6æã®æç¹ã§ç±³åœå ã®ææã®95ïŒ ãå ããŠãããã
ã»ã»ããæ±äº¬éœã®æ¹ãEG.5ã®å²åãé«ãããã ïŒïŒïŒããŒã»ã³ãïŒïŒæïŒïŒæ¥ïœïŒïŒæ¥ïŒã
ãCDCã1æã«çºè¡šããç ç©¶çµæã«ãããšãæ¢åã®2䟡ããŒã¹ã¿ãŒã¯ã¯ãã³ã¯ãäžè¬çãªæäººã§ã¯XBB系統ã«å¯ŸããŠçŽ50ïŒ ã®äºé²å¹æã65æ³ä»¥äžã§ã¯çŽ33ïŒ ã®äºé²å¹æããããã
ããŒããïŒïŒããŒã»ã³ããšããã®ã¯ãWHOãã¯ã¯ãã³ãšããŠæ¿èªããã®ãªã®ãªã®æ°å€ã ïŒäºé²å¹æïŒéåžžã¯çºçäºé²å¹æãæãïŒãšããããã©ããã ãªïŒã
ãç±³åœã§ã¯ãŸããBA系統ã®äžçš®ã§ããæ°å€ç°æ ªãBA.2.86ãïŒéç§°ããã©ïŒãåºãŸãå§ããŠãããä»ã®ãšãããCDCã®å€ç°æ ªãã©ãã«ãŒã«çŸããã»ã©ã®çäŸæ°ã¯ãªãããäžçä¿å¥æ©é¢ïŒWHOïŒã¯ããã©ãç£èŠäžã®å€ç°æ ªã®ãªã¹ãã«å ãããããã©ã®å€ç°ã®æ°ã¯ãç±³åœã§ä»å¹Žåãã«äž»æµãšãªã£ãXBB.1.5ããã36å€ããBA.2ããã34å€ããã
é ãæªãã€ããå€ãç±³åœã§ã¯ïŒãããªã®ããïŒïŒãå€ç°é±ã«ãã åãã€ããŠããšãªã¹ãšãããã©ãšãåŒãã§ããããäœèšã«æ··ä¹±ããããªæ°ãããã
ãããã©ã¯XBB系統ã§ã¯ãªããããæ°ããŒã¹ã¿ãŒãå¹ããªãå¯èœæ§ãæžå¿µãããããã¢ãã«ãã¯6æ¥ãæ°ããŒã¹ã¿ãŒã¯èšåºè©ŠéšïŒæ²»éšïŒã§ããã©ã«å¯Ÿããäžåæäœã8.7åå¢å ãããããšã確èªããããšçºè¡šãããã
ãã®èŸºã®æ å ±ã¯ãææç ã§ãè£è¶³ããŠããã
ææç ã«ããã°ããã¡ã€ã¶ãŒã®ããã©çµ¡ã¿ã®ã¬ããŒããåºãŠãããã ãããã®èšäºã§ã¯ãçŸç¶ãããããã¯ã¹ã¯åç©è©Šéšæ¢ãŸãã§ãäžæããããšä»æã®ã¯ã¯ãã³ã¯åºãªããããããªãïŒæªç¢ºèªïŒã
ãŸãããã
å®éã®æµè¡ã®äžã§ãç«åŠçã«å€å®ããªãããæ¬åœã®ãšããã¯åãããªãã
æ±äº¬éœã®ç¬¬ïŒæ³¢ããã©ããŸã§èœã¡ãŠããããããåœé¢ã®é¢å¿äºã ã
ç±³åœã¯ãå€ã®å¢å ãåŒããããªããã¯ã¯ãã³æäžã«çªå ¥ããã
ã©ãŒãããããã¯ã¯ãã³ãªããŠæµè¡ããªãã ãããããã¿ãŒããªèªç¶ææãã¡ãŸãã«éããªãïŒãããªã®ããïŒïŒã
é«éœ¢è ãã¢ãããŒããã«éçåãããããšããã®ã¯ãæŽã®æ±è¥¿ãåããåãã ã
æ°åã³ããã§éãã€ããéã£ãŠããïŒã
ç±³åœèŸºãããã培åºããŠããã ãããªã»ã»ã»ã
ïŒããã«è¿œå ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒãã¡ã€ã¶ãŒã¯ãææ°ã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãããŠã¹ã®æ°ããªå€ç°çš®ã«å¯ŸããŠåŒ·ãåå¿ãåŒãèµ·ããããšçºè¡šïŒ
https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-updated-covid-shot-generated-strong-reaction-vs-new-variant-mice-2023-09-06/
ææç ã®ã¬ããŒãã«ãªã³ã¯ãããŠããå èšäºãåœã£ãã
ãä»ç§äœ¿çšãäºå®ãããŠãããã¡ã€ã¶ãŒã»ããªã³ããã¯(22UAy.DE)ã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ããé«åºŠã«å€ç°ããBA.2.86ã«å¯Ÿãã匷åãªæäœåå¿ãèªçºãããšçºè¡šãããããŠã¹ã®åèšåºç ç©¶ã«ãããã³ãããŠã€ã«ã¹ã®äºå€ç°äœãã
ãã¢ãã«ã(MRNA.O)ã¯æ°Žææ¥åããããã察象ãšããèšåºè©ŠéšããŒã¿ã«ãããææ°ã®ã¯ã¯ãã³ãBA.2.86äºçš®ã«å¯ŸããŠæå¹ã§ããå¯èœæ§ãé«ãããšã瀺ããããšçºè¡šãããã
ãã¡ã€ã¶ãŒã¯ããŠã¹ã§ç¢ºèªããã¢ãã«ãã¯ããã察象ã«ç¢ºèªããŠããã
èšäºã«ã¯ãæ°ã«ãªãèšè¿°ãããã
ãç±³åœçŸç 管çäºé²ã»ã³ã¿ãŒã¯ä»¥åãBA.2.86ã以åã«æ°åã³ãããŠã€ã«ã¹ã«ææããããšã®ãã人ããŸãã¯ä»¥åã«ã¯ã¯ãã³æ¥çš®ãåããäººã«ææãåŒãèµ·ããå¯èœæ§ãé«ãå¯èœæ§ãããããšã瀺åããŠããŸãããã
ãŸããåçŽã«å€ç°ç®æãå€ãããšããã®æšæž¬ã ãããã©ããã¬ã€ã¯ã¹ã«ãŒææããåææãæ¥åžžçã«ãªããããªã
ã ãããæ°ããã¯ã¯ãã³ããã¡ãŸããããšããã®ããç±³åœCDCã®æèãªããšã¯èŠããŠããã
ããæç¬å¹ãã©æ±ãèžãããçžãªãè¡çã°ã£ããã®ç±³åœããããã ãªãã ããã
æãåœã¯ãäžçã«å é§ããŠã¯ã¯ãã³ãæ¿èªããã
å šäººå£ã®ïŒå²çšåºŠãã調éããªããã©ãªïŒéçåçãé«ãé«éœ¢è ã®å šæ°ã«ãè¶³ããªãïŒã
ããããã»ã»ã»ã
ä»®ã«ãããã©ïŒBA.2.86ïŒãã第äºã®ãªãã¯ãã³ã ã£ããããããççºçæµè¡ã¯ééããªãã
ç±³åœã®æ»è çµ±èšãèŠãéããXBBäºç³»çµ±ã§ããæ»è ã®å¢å ã¯èŠ³æž¬ãããŠããã
ç åæ§ãèœã¡ããšãã話ãèããªãã
ããã©ã®ç åæ§ã«ã€ããŠã®æ å ±ã¯ãªããã©ãXBBãšåçšåºŠãªããæ²æšãªçµæã«ãªãã ãããªã
ïŒïŒåäººã®ææãšïŒåäžäººã®æ»è ã ïŒããªãæ§ãããªäºæ³ã»ã»ã»ïŒã
ãªãã¯ãã³ç»å Žåå€ã®ããã®è§£æŸæã¯ææ©ãªãïŒã¯ã¯ãã³ã§ããã«ã¿æ ¹çµ¶ããããªïŒæ±äº¬éœã«ãããæ°èŠææè æ°ã¯ãäžæ¡ãŸã§èœã¡ãïŒïŒã
ã¡ãªã¿ã«ãæ±äº¬éœã«ãããæšæ¥ã®æ°èŠæšå®ææè æ°ã¯ãæžå°åŸåã«ãããšã¯ãããïŒïŒïŒïŒïŒäººã ã
ã¹ããŒãŒãã»ã»ã»ã
æ°ååã®ããŒã¹ã©ã€ã³ããã®ãæªæœæã®å€§æµè¡ãåŸ ã£ãŠããã®ãã
ãããšããäŸã«ãã£ãŠãæµ®æ²åã®ææã«çµããã®ãã
ãã®çãã¯ããããŠåããã
åãã£ãæã«ã¯ããã§ã«æé ãã ã£ãããããã ããªã»ã»ã»ã
ïŒããã«ããã«è¿œå ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒæ°ããªå€ç°æ ªãããã©ãæ¡å€§ã欧å·åœå±ãèŠåïŒã³ããææè ãå¢å ïŒ
https://www.bloomberg.co.jp/news/articles/2023-09-08/S0MZGOT1UM0W01
ãæ¬§å·çŸç äºé²ç®¡çã»ã³ã¿ãŒïŒïŒ¥ïŒ£ïŒ€ïŒ£ïŒã¯ã倧ããå€ç°ããæ°åã³ãããŠã€ã«ã¹ã®æ°ããªå€ç°æ ªãããã©ããæ¬§å·å€§éžã§åºãã£ãŠãããã³ããææè å¢å ã®èæ¯ã«ãããããããªããšèŠåãããã
欧å·ããããŸãããã»ã»ã»ã
ãã¯å£°æã§ãæ£åŒåç§°ãBA.2.86ãã®ãã®å€ç°æ ªã¯ïŒæã«æ£çºçã«ç¢ºèªããããšããæè¿ã®é¡èãªæææ¡å€§ã®èŠå ãšãªã£ãŠããå¯èœæ§ã«èšåãããã
ãããŸã§ãå¯èœæ§ãææããã ãã§ãæç¢ºãªãšããã³ã¹ããããããããªãã
ãã®ã¢ã¢ã³æé·ã¯å£°æã§ãæ°ããªå€ç°æ ªãéçåãã¯ã¯ãã³ã®å¹æäœæžãšé¢é£ããŠãã蚌æ ã¯ãªããšææãããã
ããåœå±ããããã©ãå±±è»ã«ããŠãã¯ã¯ãã³æ¥çš®ãææå¯Ÿçãæšé²ããããšããŠããããšã¯æçœã ãªã
ãååçã§ç§ãšå¬ãè¿ã¥ãäžã§ã欧å·ãªã©ã®åœå±ã¯ååœã«å¯Ÿããéçåãªã¹ã¯ã®ãã人ãäžå¿ã«ã¯ã¯ãã³æ¥çš®ãé²ããåãçµã¿ã®åŒ·åãåŒã³ãããŠãããã
åã¯ã¯ãã³ãã£ã³ããŒã³ãå±éããŠãããã¹ã³ãããã©ãåå¿ããããèŠãã®ã ã
æãåœã®æ¿åºã¯ãåŸæ¥ãïŒå²ä»¥äžãæ¥çš®ããŠããé«éœ¢è ã®å šæ°ã«ãæºããªã調éãããããŠããªãã
ã€ãŸããå šãããæ°ããªãããšãæåãã倧ã£ãŽãã«ããŠããããã ã
ãã¡ããã远å 調éãããããšãåæãšããåå調éãšãããšã¯ã¹ãã¥ãŒãºã¯ãããã©ãæ¥çš®å¯Ÿè±¡ã¯ïŒå人以äžã ãããªïŒèª¿éæ°ã¯ïŒïŒïŒïŒäžïŒã
ç±³åœã欧å·ããã©ãçšã®èª¿éãæããŠããã®ãã¯ç¥ããªãã
æµ®æ²åã¯ã以åããèªç¶ææã«ããå ç«ç²åŸãåæãšããæ¿çã ãšéé£ããŠãããã©ãå šäžççã«ããããåŸåã«ããã®ãããããªãã
ã¯ã¯ãã³ãå¹ããªãããã§ã¯ãªãããã©ããã£ããããšãã£ãŠçœ¹æ£ããªããšããããã§ããªãã
ææäºé²å¹æãçºçäºé²å¹æã¯ããã£ãŠã極å ãã§ãéçåäºé²å¹æã«ããŠããçµæçæžåŒ±ãæ¿ãããæã£ãŠå幎ããããæåŸ ãããããªãé«éœ¢è ã«è³ã£ãŠã¯ãïŒãæããããšããã ããïŒæªç¢ºèªïŒéçåäºé²å¹æã«ã€ããŠã¯ã幎霢éå±€å¥ã®å·®ã¯ãªããšãã話ãïŒã
ãããªã¯ã¯ãã³ã§ãããªãããã¯ãã·ã ã
ããã©ãå±±è»ã«äœ¿ãæã¯ãã©ããåãã ã
ã€ãŒãã䜿ãããã®ã¯äœã§ã䜿ãã
è³ãçºéãããåç©ãšããŠã¯ãæ å ±ã«ãã£ãŠè¡åãå€å®¹ãããªããã°å€±æ Œã ãããªã»ã»ã»ã
ïŒãŸã远å ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒã³ããã¯ã¯ãã³ãåœè²»ã§ã®ç¡ææ¥çš®çµäºãžã65æ³æªæºã¯ååèªå·±è² æ ïŒ
https://mainichi.jp/articles/20230907/k00/00m/100/298000c
ã65æ³ä»¥äžã®é«éœ¢è ãªã©éçåãªã¹ã¯ãé«ã人ã®å Žåãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãšåãã§ãè²»çšã®äžéšãåœã®äº€ä»éã§ãŸããªãã宿æ¥çš®ãã«äœçœ®ã¥ããç§å¬ã«1å宿œããæ¹åã§èª¿æŽããŠãããã
ã¯ã¯ããããã§ç¬¬ïŒæ³¢ãããªãã£ãŠèšã£ãŠãã®ããã»ã»ã»ã
ãããã®è«çã¯éçšããªãã ãããªã
ç¬¬ïŒæ³¢ãè¶ ããèŠæš¡ã§æµè¡ããæ»è ãçžåœæ°åºãŠããã«éããªãã
ã¯ã¯ãã³ãšããã®ã¯ãæµè¡ã«å ç«ã£ãŠæ¥çš®ããæµè¡ãã®ãã®ãæããããšã«ãã£ãŠãææãçºçãéçåãäºé²ããããã®ããã ã
æãããªå€å£ã®æµè¡ãèªããããã«ãããããããã¯ã¯ãã³æ¥çš®ãããªãçç±ãã©ã説æããã€ãããªã®ãã
ãšããã³ã¹ã«åºã¥ãæ¿çã§ã¯ãªããè¡æ¿çéœåã§ããããŒã«ã§ã£ã¡äžããŠãäžžã蟌ãããšããŠããã
ãŸãããã
æãåœã¯ç±åž¯åãã€ã€ãããããªã
ãã®ãã¡ãã€ã³ãã«ãå€å£ã«æµè¡ããããã«ãªããããããªãïŒãããªã®ããïŒïŒïŒãŸããŸã远å ïŒåç §ïŒã
ãããªãã°ã幎ïŒåã®ã¯ã¯ãã³æ¥çš®ãšããã®ãåžžæ ã«ãªãå¯èœæ§ãããã
éçåäºé²ã®èгç¹ãããã幎ïŒåãšããã®ã¯é£ããã ããã
çµæçæžåŒ±ãæ¿ããæ°åã³ããã¯ã¯ãã³ã®å Žåãå¬å£ã ãã§ãæã€ãã©ãããæªãããããã ã
æµ®æ²åã¯ã仿ãã€ãã©ããããã幎å ãããããå¹ãç®ã¯ãªããšèŠãŠããã
æ¥å¹Žã«ãªã£ããããã³ãã³çœ¹æ£ãããããªã
ããããã»ã»ã»ã
ä»æã®æµè¡ã§ã眹æ£ããã«æžããšã¯æããªãã
幎æ«ä»¥éã¯æãåãåŒãç± ãäºå®ã ãã©ãæµè¡ç¶æ³ã«ãã£ãŠã¯é¿ããããªãã ããã
ïŒã·ãŒãºã³ãæããªãã¯ã¯ãã³ããã£ãŠãããŠãããã§å¹ŽéåŒã£åŒµãããšããã®ã¯ç¡çãããã
æµè¡ãæããããšããæ°ã¯ãããããªããããã£ããã©ãããã€ãããªãã ãããã
ãã£ã±ãèªç¶ææããŠãããšããã®ãæ¬é³ã ãšæããããåŸãªãã
ïŒïŒïŒïŒäžä»¶ããã¯ã¯ãã³èª¿éããªãã§ãããèšããã»ã»ã»ã
ïŒãŸããŸã远å ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒã€ã³ãã«ãšã³ã¶ã®æµè¡ç¶ããåæããæ¬¡ã®ã·ãŒãºã³å ¥ãã¯99幎以éåïŒ
https://news.yahoo.co.jp/articles/074e04f59c832fda0d10680ec7eff2c56460280b
ãå šåœçŽ5åã«æã®å®ç¹å»çæ©é¢ããå ±åãããææ°1é±éïŒ8æ28æ¥ïœ9æ3æ¥ïŒã®å£ç¯æ§ã€ã³ãã«ãšã³ã¶ã®æ£è æ°ãã1å»çæ©é¢ãããã2ã»56人ïŒéå ±å€ïŒãã ã£ããã1人ããè¶ ããšãæµè¡ããšãããæšå¹Ž12æ19ïœ25æ¥ã«æµè¡æå ¥ãããããšããããŸã§äžåºŠãäžåã£ãŠããªããã
ãæµè¡ãåæããªããŸãŸæ¬¡ã®ã·ãŒãºã³ã«çªå ¥ããã®ã¯ãçŸåšã®æ¹æ³ã«ãªã£ã1999幎以æ¥ãåããŠãšãããã
ããããã»ã»ã»ã
ãæµè¡ãç¶ããŠããèæ¯ãšããŠã3幎éã€ã³ãã«ã®æµè¡ããªãã£ãããšããæšå¹Žã®ã¯ã¯ãã³æ¥çš®ããæéããã£ãããšã§ã1äººãææãããšåšå²ã«åºãããããç¶æ³ããããšææããããŸããæ°åã³ããã®5é¡ç§»è¡ã§ææå¯Ÿçãç·©ãã ããšããããšãããã
äœããç®ã«èŠããªããšããã§ãéãã«å€§ããå€ãã£ãŠããããšããããã ããã
ææçã®æµè¡ãå ç«ã®äœäžã¯ããã®å€§ããªåãã衚é¢åããäžéšåãªã®ã«éããªãã
æãåœã®ããã«ãå¹³åã§éç©ãªç¶æ³ã§ãªããã°ããã®ä»ã®ãã€ãºã«ããæ¶ãããŠããŸãçšåºŠã®åŸ®åŠãªå€åã
å人ã®ã¬ãã«ã§ã¯ããªããšãªããã€ããšéãçšåºŠã«ããæããããªãããããããã®éãã
ãã£ã±ãå°ç£æ°ç°åžžãšããç°æäººã®æ»æãšãããããªãã¯ã¹ã®ãã°ãšããããããã¯ã±ã¯ã«ãªè©±ã«ãªããã ãããïŒïŒããã¯ããã§ãå«ããããªããã§ããã©ïŒã
ïŒå°ç£æ°ã¯äººäœã«åœ±é¿ããŸããïŒïŒ
https://www.isee.nagoya-u.ac.jp/50naze/chijiki/46.html
ãæ±æŽå»åŠã§ã¯ãç£æ°ãå¥åº·ã«åœ±é¿ãåãŒããæ°ãã®äžçš®ãšã¿ãªãããŠããŸãã ããããèªç¶ç§åŠã®ç«å Žããèšãã°ãå°ç£æ°ã人ã®å¥åº·ã«çŽæ¥åœ±é¿ããããšã¯ãªããšèããããŸãã ãã®ããšã¯ãå°ç£æ°ã人ãå«ãçåœã®å¥åº·ç¶æ ãšç¡é¢ä¿ã§ãããšããæå³ã§ã¯ãããŸãããã
ããŒããçŠ åçã®ãããªåçã ãªã
ãäŸãã°ãå°ç£æ°ã匱ããªãã°å®å®è¹ã®ç §å°ãå¢ãã人ã®å¥åº·ã«ç倧ãªåœ±é¿ãåãŒãããšã«ãªããšäºæ³ãããŸãã
ã€ãŸãããçŽæ¥çãªåœ±é¿ãã¯ãªããã©ãã鿥çãªåœ±é¿ãã¯ãããšããããšãã
ïŒïŒïŒïŒå¹Žå®å®ã®åºŠã§ã¯ããã³ã¯ã¬ãŒã¿ãŒã®å°ç£æ°ç°åžžãããã¢ããªã¹ãçºèŠããŠããŸããšããçæžãã ã£ãèšæ¶ãããã
ïŒã¢ããªã¹(2001幎å®å®ã®æ )ïŒ
https://dic.pixiv.net/a/%E3%83%A2%E3%83%8E%E3%83%AA%E3%82%B9%282001%E5%B9%B4%E5%AE%87%E5%AE%99%E3%81%AE%E6%97%85%29
ãTMA-1
æé¢ã®ãã³ã¯ã¬ãŒã¿ãŒä»è¿ã§çºèŠãããç£æ°ç°åžžã®æ£äœããã³ç£æ°ç°åžžïŒTycho Magnetic AnomalyïŒããšããŠãæã®å°äžããçºæãããç©äœãã
ãŸããã©ãã§ããããã§ããã
ïŒå°ç£æ°ïŒå°ç£æ°ã®å€åã®å°çç°å¢ãžã®åœ±é¿ïŒ
https://ja.wikipedia.org/wiki/%E5%9C%B0%E7%A3%81%E6%B0%97#%E5%9C%B0%E7%A3%81%E6%B0%97%E3%81%AE%E5%A4%89%E5%8B%95%E3%81%AE%E5%9C%B0%E7%90%83%E7%92%B0%E5%A2%83%E3%81%B8%E3%81%AE%E5%BD%B1%E9%9F%BF
ãå°ç£æ°ã匱ãŸãäºã«ããã倧æ°åå ãžã®å®å®ç·ã®å ¥å°éãå¢å€§ããããšã«ããã倧æ°äžã®éå·åŽæ°Žèžæ°ãå®å®ç·ã®é£è·¡ãæ žãšããŠåçµãããããé²ã®éãå¢å ããŠæ¥å°éã«åœ±é¿ãäžããããŸããå°è¡šã«å°éããå®å®ç·ã®å¢å ã«ãããçç©ã®ããªãã·ãªãæ žé žãæå·ãã確çãé«ãŸããããçªç¶å€ç°ã®å¢å ããäžå ãšãèãããããã
ããããå°ç£æ°å転ããããã®ã§ã¯ãªãããšããå°ç£æ°ã®æžåŒ±ãç¶ããŠãããšããã話ã¯ããèãã
ãé¢é£ããæ åäœåïŒ
ããã¥ã¡ã³ã¿ãªãŒããµã€ãšã³ã¹ã»ã¯ãŒã«ããã·ãªãŒãº 第6åãå°çã®èŠãããçŸãïŒãã·ã§ãã«ã»ãžãªã°ã©ãã£ãã¯ïŒã
é²ç»ããŠãäœåºŠãèŠè¿ããŠãããã ããã ãã¶æŽè³ããã¡ãŸã£ãŠãã®ãããããªãã
ãããã«ããŠããä»å¹Žã®å€ã®æãã¯ç°åžžã ã£ãã
å ç«ãäœäžãããããã¯ãæ³å®ã®ç¯å²å ã ãããªã»ã»ã»ã
ïŒå€ç°æ ªã«ã€ããŠïŒ
https://www.hokeniryo.metro.tokyo.lg.jp/kansen/corona_portal/henikabu/screening.html
ïŒã²ãã è§£æçµæã®æšç§»ïŒé±å¥ïŒ
ïŒä»€åïŒå¹ŽïŒæïŒæ¥ïŒïŒææç¹ïŒïŒ
https://www.hokeniryo.metro.tokyo.lg.jp/kansen/corona_portal/henikabu/screening.files/genomu0509071.pdf
ã°ã©ããèŠããšãEG.5ãå¢å åŸåãªããšãåããã
XBB.1.6ã眮ãæãã€ã€ããããã«ãèŠããããäœãšãèšããªãã
äž¡è ãåããããšéåæ°ãªç¶æ³ãç¶ããŠããã
ãã®ä»ãXBBäºç³»çµ±ã®å²åã«å€§ããªå€åã¯ãªããæ³šç®ãããŠããBA.2.86ã¯ãçµ±èšã«ã¯ãŸã ä¹ã£ãŠããªãïŒïŒäŸãæ€åºãããã°ããïŒã
éçåçãå°ãããšããããšã¯ãå»çè³æºãå§è¿«ããããšãªããéãããæ²»çäœå¶ã§åãã§è¡ããããšãæå³ããã
æµè¡ã®å¢å çã«ã€ããŠãåãã ã
æ°åã³ããã¯ãä»ã§ã¯ã»ãšãã©ã®å Žåãæ²»çå¯èœãªç æ°ã ãããªã
ããã§ãé«éœ¢è ãªã©ã¯éçåããããæ»ã«è³ãç ã§ããããšã«å€ããã¯ãªãã
眹æ£ããã«æžãã°äœããã ããã¯ã¯ãã³ãã£ãŠéçåãé²ãããªããã€ã®ãããã«æ±ºãŸã£ãŠããã
ãã¡ã€ã¶ãŒãã»ã»ã»ã
æéã®ïŒåç®æ¥çš®ãéžæãããã ããïŒïŒæïŒæ¥ããã®ã¢ãã«ãã§ãè¯ãã£ããããªïŒãããããå¯åå¿ã¯ããã€ïŒïŒã
ãã®éããã€ãã³ã°ãïŒã€ã»ã©ã€ã¶ããŠããïŒããŒããä¹ ã ã®ããã«ã¿ã³ã¯ã ã£ãã®ã«ã»ã»ã»ïŒã
å¯ãåé¿ãã芳ç¹ããããã£ã³ã絡ã¿ã®ã€ãã³ãããã¹ããã
ã¡ãã·ã³è¡ãã®ããã®ãã¬ãŒãã³ã°ã«çµã£ãŠãå¿ èŠæå°éã®è¡åãããšããªãã
ïŒïŒæã«å ¥ãã°ãçš²åå宿ïŒãã¶ãäžäººïŒãåéããã
蹎ã£ãŠè¹Žã£ãŠè¹ŽããŸãããæŽããŠæŽããŠæŽããŸããã
èªåã®æè¶³ã®å»¶é·ãšããŠãç¡æèã«åšæãæ±ããããã«ãªããŸã§ç¹°ãè¿ãè¡ãã
座åŠã®äºç¿ãããŠãããªããšãªïŒãŸã ååããèªãã§ãªãïŒã
æµ®æ²åã¯ãå³å¯ã«ã¯çåŸãããªããã©ãåãããã«åå ããã
ãã¡ã³ãã€ãå Œãã¬ãŒãã³ã°ãã€ãå Œè¬ç¿ååè¬ã ã
ãŸãããã
ã¡ãã·ã³ã§ããã®ãšãäœãæµè¡ããŠãããã¯åãããªãã
ãã©ã€ãã«ã«ã«ã¡ã³ã¯ãç±³åœã®è£åºã¿ãããªããã ãããªã
ç±³åœã§æµè¡ããŠããå€ç°çš®ãããã®ãŸãŸèå»¶ããŠãããã ããã
ãã¡ãããæ è¡è ã¯èª°ããã¹ã¯ãªããŠããŠããªããã
ããããã»ã»ã»ã
ïŒå¹Žåã®æ©ç§ããªãã¯ãã³æµè¡åå€ããŸãã«åœåãããïŒïŒæïŒïŒæ¥ã«ãæµ®æ²åã¯æç°ããåã®ã¡ãã·ã³è¡ãã®äŸ¿ã«ä¹ã£ãïŒANAã®ã¡ãã·ã³ã·ãã£ãŒè¡ãïŒã
ã¡ãã·ã³è¡ããšãæ°ããªå€ç°çš®ã®ç»å Žãšã®æªããé¢ä¿ã»ã»ã»ã
ä»ãæ¥çã§æ³šç®ãéããŠããBA.2.86ã¯ããªãã¯ãã³åæ§ãå€ãã®å€ç°ãéããŠãéãã«æµè¡ã®ã¿ã€ãã³ã°ãèšããªããæœäŒããŠããã
ã¢ã«ãã¡ã®æµè¡ã®éããå€ãã®å€ç°ãèç©ãããŠãããšããã
äžè¬ã«ãé«ç åæ§ã®ãŠã€ã«ã¹ã¯ãåºãæµè¡ããããšã¯å°ãªãã
ã ã£ãŠãå®¿äž»ãæ»ãããŸã£ããå ãåããªããããªã
äžæãå ±åããããã«ã¯ããããŸã¬ã³ã¬ã³å¢æ®ãããã宿䞻ã®è³æºãé£ãã€ã¶ãããããã«ã倧人ããããŠããã®ãæå©ãšããããŠããã
ããããïŒïŒïŒïŒå¹Žã«è¥¿ã¢ããªã«ã§æµè¡ãããšãã©ã¯ãé«ç åæ§ã®ææçãèªç©ºæ©ã«ãã£ãŠãå šäžçã«åºãããªã¹ã¯ãæããã«ããïŒèŽæ»çã¯ïŒïŒããŒã»ã³ãè¶ ïŒã
çŸåšããã®ãªã¹ã¯ã¯ããã«é«ãŸã£ãŠããã
æ°åã³ãããæªæ¥æ°žå«ãé«ç åæ§ã«å€ç°ããããšã¯ãªããšããäžãäžãããªã£ãŠããå®¿äž»ã®æ»äº¡ãªã©ã§æµè¡ãæå¶ãããããå¿é ã«ã¯åã°ãªããªã©ãšããããšã¯ã誰ã«ãèšããªãã
ããã®å ç«ãåé¿ããèœåãç ãæŸãŸããæ°ããªæµè¡ã®ãã£ã³ã¹ããããã£ãŠããã
ãã¡ããããŠã€ã«ã¹ã«ãããªæŠç¥ã¯ãªãã
人é¡ãšåãã ãããã®å°äžã§é²åãç¶ããçç©ãšããŠïŒçç©ãªã®ããïŒïŒå ±åããŠããã ãã ã
å€ç°ãããæ°åã³ãããŠã€ã«ã¹ã®ç骚é ã ã
ãã®å€ç°ã®ããŒã¹ãææé床ã墿®èœåãç åæ§ããšãã»ãšãã»ããçŸä»£ã®äººé¡ã®ç掻æ§åŒïŒéœåžç掻è ã®å¢å ãèªç©ºæ©ç§»åãå«ãïŒã«ãŽã£ãããšãããããçµæããäžççãªå€§æµè¡ãçãã
æµ®æ²åçã«ã¯ãç¡çåæ§ãã£ãªã¢ããã®ææå²åã®å€ããæ°ã«ãªããšããã ã
ã¯ãç·æ¥äºæ 宣èšãè§£é€ããããèŠæãè§£ããããã§ã¯ãªãã
åœç«ææçç ç©¶æããBA.2.86系統ã«ã€ããŠæ¬æ¥ã¬ããŒãããªãªãŒã¹ããŠããã
ïŒæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã®å€ç°æ ª BA.2.86系統ã«ã€ããŠïŒ
https://www.niid.go.jp/niid/ja/2019-ncov/2551-cepr/12240-sars-cov-2-ba-2-86.html
ã2023幎9æ7æ¥ãŸã§ã«67ä»¶(ã€ã¹ã©ãšã«3ä»¶ããã³ããŒã¯12ä»¶ãç±³åœ7ä»¶ãè±åœ8ä»¶ãåã¢ããªã«16ä»¶ããã«ãã¬ã«2ä»¶ãã¹ãŠã§ãŒãã³5ä»¶ãã«ãã2ä»¶ããã©ã³ã¹6ä»¶ãã¹ãã€ã³3ä»¶ããªãŒã¹ãã©ãªã¢1ä»¶ãéåœ1ä»¶ãæ¥æ¬1ä»¶)ã®æ£è ããåé¢ã
ãåœå ã§ã¯9æ7æ¥ã«æ±äº¬éœããGISAIDã«ç»é²ãããBA.2.86.1系統1ä»¶ã®ã¿ã確èªãããŠãããæ±äº¬éœããå ±åããã1ä»¶ã«ã€ããŠã¯ã8æ24æ¥ã«éœå å»çæ©é¢ã§æ¡åãããæ€äœã§ããããšãå ¬è¡šãããŠããã
ãBA.2.86系統ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã«BA.2ç³»çµ±ãšæ¯èŒããŠ30以äžãXBB.1.5ç³»çµ±ãšæ¯èŒããŠ35以äžã®ã¢ããé žã®éããããããšãããã¯ã¯ãã³ãææã«ããäžåæäœã«ããå ç«ããéé¿ããå¯èœæ§ãçããŠãããã
ãçŸæç¹ã§ãéç床ã®å€åãæææ§ã«é¢ããç«åŠçãèšåºçç¥èŠã¯ãªããã
ãæ€æ»ãžã®åœ±é¿ã«é¢ããŠãåœç«ææçç ç©¶æã§ã¯BA.2.86系統ã®ã²ãã è§£æçµæããææç PCRæ³ã«ããããã©ã€ããŒããããŒãé åã«å€ç°ããªãããšã確èªããŠããã
ãç§ä»¥éã«æ¥çš®ã宿œãããXBB.1.5系統察å¿ïŒäŸ¡ã¯ã¯ãã³ãçç£ã販売ããŠãããã¡ã€ã¶ãŒç€Ÿãã¢ãã«ã瀟ã¯ããããçŸåšæºåäžã®ã¯ã¯ãã³ã«ãããŠãBA.2.86系統ã«å¯Ÿããäžå掻æ§ã確èªããã
ãCDCã¯è€æ°ã®ç±³åœæ¿åºæ©é¢ã®å°éå®¶ã§æ§æãããSARS-CoV-2 Interagency Group (SIG)ã®æèŠãšããŠã BA.2.86ç³»çµ±ã®æããã¢ããé žå€ç°ããã¯ããã«ããã¬ã«ãã«ã»ãªãããã«ãã¬ã ãã·ãã«ãã¢ã«ããã©ãã«ãªã©ã®çŸåšäœ¿çšå¯èœãªCOVID-19ã«å¯ŸããæãŠã€ã«ã¹è¬ã¯BA.2.86系統ã«å¯ŸããŠãæå¹æ§ã瀺åããããšããŠããã
ããŒããä»ã®ãšãããå ·äœã«å€§éšãããªããã°ãªããªãç¶æ³ã«ã¯ãªãããã ãªã
ãæ€åºæ°ã¯å°ãªããã®ã®ãæ¢åã®å€ç°æ ªãšæ¯èŒããã¢ããé žã®éããå€ãããšãããWHOã¯8æ17æ¥ã«ã欧å·çŸç äºé²ç®¡çã»ã³ã¿ãŒ(ECDC)ã¯8æ24æ¥ã«BA.2.86系統ãç£èŠäžã®å€ç°æ ª(VUMïŒVariants Under Monitoring)ã«æå®ããã
ããã€ã倧åããããšãã䌌ããããªã®ãåºãŠããŠæµè¡ãå éãããããªããšã«ãªãã°ãå šäžççã«ææå¯ŸçãæŸæ£ããŠããçŸç¶ã¯ããŠã€ã«ã¹ã«ãšã£ãŠã¯å€©åœãã®ãã®ã ãããªã
ãã£ãšããéã«åºããã ããã
ãŸããåºãã£ãŠãåãããªããšããããšãããïŒæ€æ»ããŠãªããïŒã
ãã¡ãããæµè¡ããªãæ¹ãããããç åæ§ãäžãããªãæ¹ãããã«æ±ºãŸã£ãŠããã
æµ®æ²åã¯ãé«éœ¢è ã§æç æã¡ã ã
ãã€ãã³ã°ãªã©ãšãããããã§ãªããŠããªã¹ããŒãªè¶£å³ãæã¡ããããç¶ããããã«ãææã®ãªã¹ã¯ãé«ããã£ãããã¹ã«éã£ãŠããïŒä»æ¥ã¯å°é¢šã§ãµãããŸãããïŒã
åšå²ã¯ãææçµéšè ã ããã«ãªã£ãŠãããããã€çœ¹æ£ããŠãããããã¯ãªãã
æ°åã³ããã«é¢ããŠãäœãç¥èãåŸããããšãã£ãŠãè¡åã«å€§ããªå€åãäžããããšã¯ãªãã
è³ãçºéãããåç©ãšããŠã¯å€±æ Œã ãªã
ãªã¹ã¯ãåé¿ããçå確çãäžããè¡åã«ç¹ãããªããã°ãç²åŸããæ å ±ãæå¹ã«æŽ»çšããŠãããšã¯èšããªãã
ãã€ãã®ããã«çé£ãããã€ãã®ããã«çç¡ããã
çµæããªããŠã³ãããŠéããªããæ ãŠãŠå·æ¿ã®å¹ãããã£ãããã¹ã§éåããŠæ±ãããïŒççŸããŠãïŒïŒã
ãŸããã©ãã§ããããã§ããã
ã¯ã¯ãã³æ¥çš®ã®æ¥çšãåªå ãããŠãããã«ã¿ã³ã¯ã®ãã¬ãŒãã³ã°ãã€ãããã¹ããããšãšãå¯åé¿ãçç±ã«é«æãã€ãã³ã°ããã¹ããçšåºŠã ã
ãã£ãããã¹ãããŒãã®ãã«ãŠã³ãããŠããããããããªãïŒãããªãïŒïŒã
確èªããŠãããã
æ±äº¬éœã®ç¬¬ïŒæ³¢ã¯ããŒã¯ã¢ãŠãããæµè¡äžã®å€ç°çš®ã¯EG.5系統ãå¢å ããŠããã
æ¬æ¥çŸåšãå šåœã®ïŒïŒæ³ä»¥äžã®æšå®ææè æ°ã®å¢å ã¯ç¶ããŠããã
ãŠã¯ã©ã€ãçŽäºã¯ç¶ããŠããããäžçã¯æŠã宿³°ã ã
æ°åã³ããã§ã¯ãïŒå¹Žäœãã®éã«ãå šäžçã§æ°çŸäžäººãæ»ãããŸã£ããããŠã¯ã©ã€ãã§ã¯ãïŒå¹Žåã§ããããæ°åäžäººã®æ»å·è ã ã
人é¡ãæã殺ããŠããã®ãç«ç ã§ããããšã¯å€ãããªãã
æã ã¯ãããã宿åœãšããŠåãå ¥ããããåŸãªãã
æ°åã³ããã§éãã€ããéã£ãŠããïŒã
ãžãžããäžå¿ã®éçåãªããã ãããäžéã®é¢å¿ã¯äœãã
瀟äŒäžå®ã®å¿é ã¯æ¶ããã
ããããã¯äžæã®è©±ã ããããããªãã
äžå¯žå ã¯éã®æ°åã³ããã
ãã®æªæ¥ãç §ããããã³ããã«ãã©ã€ãã¯ãã©ãã«ã売ã£ãŠããªãã®ã ã»ã»ã»ã
ïŒä»¥äžè¿œå ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒã³ããæ»è å¢å ã®ç±³åœã次æã¯ã¯ãã³ã8æ¥ã«ãæ¿èªãžïŒ
https://forbesjapan.com/articles/detail/65859
ç±³åœã®ææç¶æ³ãã¬ããŒãããèšäºãäžãã£ãŠããã®ã§ãªã³ã¯ããŠããã
ãæ¬¡æã¯ã¯ãã³ã¯ãç±³åœã§ã¯åããŠæ¥çš®ãç¡æåãããªãã³ããã¯ã¯ãã³ãšãªãããã¡ã€ã¶ãŒãšã¢ãã«ãã®äž¡ç€Ÿã¯ãæ°ã¯ã¯ãã³ã®æ¥çš®è²»çšã1å110ïœ130ãã«ïŒçŽ1äž6000ïœ1äž9000åïŒãšèŠç©ãã£ãŠããããã ããä¿éºäŒç€Ÿã®å€ããæ¥çš®è²»çšãè² æ ããèŠèŸŒã¿ã§ãç¡ä¿éºè ã«å¯ŸããŠã¯CDCãè²»çšãè² æ ããããã°ã©ã ãä»ç§éå§ãããã
ç±³åœã§ã¯ãæ¢ã«ã¯ã¯ãã³ã¯ææåã ã
éã®åãç®ãåœã®åãç®ã»ã»ã»ã
ãã³ããé¢é£ã®æ»è ãšå ¥é¢ã¯åå€ããå¢å ããŠãããç§ããå¬ã«ãããŠãå¢å ãããšäºæ³ãããŠãããCDCã®ææ°ããŒã¿ã«ãããšãæ»è ã¯7æ8æ¥ïœ8æ26æ¥ã«çŽ18ïŒ å¢å ããå ¥é¢ã¯7æ28æ¥ãã8æ26æ¥ã®éã«çŽ16ïŒ å¢å ãããã
æãåœã§ã¯ãæ»è æ°ã®çµ±èšãæŸæ£ãããããªïŒæããã«ãªãã®ã¯ãïŒãæåŸã ïŒã
ãç±³åœã§çŸåšäž»æµãšãªã£ãŠããã®ã¯ãXBB系統ã®1ã€ã§ãããEG.5ãïŒéç§°ãšãªã¹ïŒã§ã8æ20æ¥ïœ9æ2æ¥ã®å šçäŸã®çŽ22ïŒ ãå ããŠãããFDAã«ãããšãXBB系統ã¯6æã®æç¹ã§ç±³åœå ã®ææã®95ïŒ ãå ããŠãããã
ã»ã»ããæ±äº¬éœã®æ¹ãEG.5ã®å²åãé«ãããã ïŒïŒïŒããŒã»ã³ãïŒïŒæïŒïŒæ¥ïœïŒïŒæ¥ïŒã
ãCDCã1æã«çºè¡šããç ç©¶çµæã«ãããšãæ¢åã®2䟡ããŒã¹ã¿ãŒã¯ã¯ãã³ã¯ãäžè¬çãªæäººã§ã¯XBB系統ã«å¯ŸããŠçŽ50ïŒ ã®äºé²å¹æã65æ³ä»¥äžã§ã¯çŽ33ïŒ ã®äºé²å¹æããããã
ããŒããïŒïŒããŒã»ã³ããšããã®ã¯ãWHOãã¯ã¯ãã³ãšããŠæ¿èªããã®ãªã®ãªã®æ°å€ã ïŒäºé²å¹æïŒéåžžã¯çºçäºé²å¹æãæãïŒãšããããã©ããã ãªïŒã
ãç±³åœã§ã¯ãŸããBA系統ã®äžçš®ã§ããæ°å€ç°æ ªãBA.2.86ãïŒéç§°ããã©ïŒãåºãŸãå§ããŠãããä»ã®ãšãããCDCã®å€ç°æ ªãã©ãã«ãŒã«çŸããã»ã©ã®çäŸæ°ã¯ãªãããäžçä¿å¥æ©é¢ïŒWHOïŒã¯ããã©ãç£èŠäžã®å€ç°æ ªã®ãªã¹ãã«å ãããããã©ã®å€ç°ã®æ°ã¯ãç±³åœã§ä»å¹Žåãã«äž»æµãšãªã£ãXBB.1.5ããã36å€ããBA.2ããã34å€ããã
é ãæªãã€ããå€ãç±³åœã§ã¯ïŒãããªã®ããïŒïŒãå€ç°é±ã«ãã åãã€ããŠããšãªã¹ãšãããã©ãšãåŒãã§ããããäœèšã«æ··ä¹±ããããªæ°ãããã
ãããã©ã¯XBB系統ã§ã¯ãªããããæ°ããŒã¹ã¿ãŒãå¹ããªãå¯èœæ§ãæžå¿µãããããã¢ãã«ãã¯6æ¥ãæ°ããŒã¹ã¿ãŒã¯èšåºè©ŠéšïŒæ²»éšïŒã§ããã©ã«å¯Ÿããäžåæäœã8.7åå¢å ãããããšã確èªããããšçºè¡šãããã
ãã®èŸºã®æ å ±ã¯ãææç ã§ãè£è¶³ããŠããã
ææç ã«ããã°ããã¡ã€ã¶ãŒã®ããã©çµ¡ã¿ã®ã¬ããŒããåºãŠãããã ãããã®èšäºã§ã¯ãçŸç¶ãããããã¯ã¹ã¯åç©è©Šéšæ¢ãŸãã§ãäžæããããšä»æã®ã¯ã¯ãã³ã¯åºãªããããããªãïŒæªç¢ºèªïŒã
ãŸãããã
å®éã®æµè¡ã®äžã§ãç«åŠçã«å€å®ããªãããæ¬åœã®ãšããã¯åãããªãã
æ±äº¬éœã®ç¬¬ïŒæ³¢ããã©ããŸã§èœã¡ãŠããããããåœé¢ã®é¢å¿äºã ã
ç±³åœã¯ãå€ã®å¢å ãåŒããããªããã¯ã¯ãã³æäžã«çªå ¥ããã
ã©ãŒãããããã¯ã¯ãã³ãªããŠæµè¡ããªãã ãããããã¿ãŒããªèªç¶ææãã¡ãŸãã«éããªãïŒãããªã®ããïŒïŒã
é«éœ¢è ãã¢ãããŒããã«éçåãããããšããã®ã¯ãæŽã®æ±è¥¿ãåããåãã ã
æ°åã³ããã§éãã€ããéã£ãŠããïŒã
ç±³åœèŸºãããã培åºããŠããã ãããªã»ã»ã»ã
ïŒããã«è¿œå ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒãã¡ã€ã¶ãŒã¯ãææ°ã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãããŠã¹ã®æ°ããªå€ç°çš®ã«å¯ŸããŠåŒ·ãåå¿ãåŒãèµ·ããããšçºè¡šïŒ
https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-updated-covid-shot-generated-strong-reaction-vs-new-variant-mice-2023-09-06/
ææç ã®ã¬ããŒãã«ãªã³ã¯ãããŠããå èšäºãåœã£ãã
ãä»ç§äœ¿çšãäºå®ãããŠãããã¡ã€ã¶ãŒã»ããªã³ããã¯(22UAy.DE)ã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ããé«åºŠã«å€ç°ããBA.2.86ã«å¯Ÿãã匷åãªæäœåå¿ãèªçºãããšçºè¡šãããããŠã¹ã®åèšåºç ç©¶ã«ãããã³ãããŠã€ã«ã¹ã®äºå€ç°äœãã
ãã¢ãã«ã(MRNA.O)ã¯æ°Žææ¥åããããã察象ãšããèšåºè©ŠéšããŒã¿ã«ãããææ°ã®ã¯ã¯ãã³ãBA.2.86äºçš®ã«å¯ŸããŠæå¹ã§ããå¯èœæ§ãé«ãããšã瀺ããããšçºè¡šãããã
ãã¡ã€ã¶ãŒã¯ããŠã¹ã§ç¢ºèªããã¢ãã«ãã¯ããã察象ã«ç¢ºèªããŠããã
èšäºã«ã¯ãæ°ã«ãªãèšè¿°ãããã
ãç±³åœçŸç 管çäºé²ã»ã³ã¿ãŒã¯ä»¥åãBA.2.86ã以åã«æ°åã³ãããŠã€ã«ã¹ã«ææããããšã®ãã人ããŸãã¯ä»¥åã«ã¯ã¯ãã³æ¥çš®ãåããäººã«ææãåŒãèµ·ããå¯èœæ§ãé«ãå¯èœæ§ãããããšã瀺åããŠããŸãããã
ãŸããåçŽã«å€ç°ç®æãå€ãããšããã®æšæž¬ã ãããã©ããã¬ã€ã¯ã¹ã«ãŒææããåææãæ¥åžžçã«ãªããããªã
ã ãããæ°ããã¯ã¯ãã³ããã¡ãŸããããšããã®ããç±³åœCDCã®æèãªããšã¯èŠããŠããã
ããæç¬å¹ãã©æ±ãèžãããçžãªãè¡çã°ã£ããã®ç±³åœããããã ãªãã ããã
æãåœã¯ãäžçã«å é§ããŠã¯ã¯ãã³ãæ¿èªããã
å šäººå£ã®ïŒå²çšåºŠãã調éããªããã©ãªïŒéçåçãé«ãé«éœ¢è ã®å šæ°ã«ãè¶³ããªãïŒã
ããããã»ã»ã»ã
ä»®ã«ãããã©ïŒBA.2.86ïŒãã第äºã®ãªãã¯ãã³ã ã£ããããããççºçæµè¡ã¯ééããªãã
ç±³åœã®æ»è çµ±èšãèŠãéããXBBäºç³»çµ±ã§ããæ»è ã®å¢å ã¯èŠ³æž¬ãããŠããã
ç åæ§ãèœã¡ããšãã話ãèããªãã
ããã©ã®ç åæ§ã«ã€ããŠã®æ å ±ã¯ãªããã©ãXBBãšåçšåºŠãªããæ²æšãªçµæã«ãªãã ãããªã
ïŒïŒåäººã®ææãšïŒåäžäººã®æ»è ã ïŒããªãæ§ãããªäºæ³ã»ã»ã»ïŒã
ãªãã¯ãã³ç»å Žåå€ã®ããã®è§£æŸæã¯ææ©ãªãïŒã¯ã¯ãã³ã§ããã«ã¿æ ¹çµ¶ããããªïŒæ±äº¬éœã«ãããæ°èŠææè æ°ã¯ãäžæ¡ãŸã§èœã¡ãïŒïŒã
ã¡ãªã¿ã«ãæ±äº¬éœã«ãããæšæ¥ã®æ°èŠæšå®ææè æ°ã¯ãæžå°åŸåã«ãããšã¯ãããïŒïŒïŒïŒïŒäººã ã
ã¹ããŒãŒãã»ã»ã»ã
æ°ååã®ããŒã¹ã©ã€ã³ããã®ãæªæœæã®å€§æµè¡ãåŸ ã£ãŠããã®ãã
ãããšããäŸã«ãã£ãŠãæµ®æ²åã®ææã«çµããã®ãã
ãã®çãã¯ããããŠåããã
åãã£ãæã«ã¯ããã§ã«æé ãã ã£ãããããã ããªã»ã»ã»ã
ïŒããã«ããã«è¿œå ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒæ°ããªå€ç°æ ªãããã©ãæ¡å€§ã欧å·åœå±ãèŠåïŒã³ããææè ãå¢å ïŒ
https://www.bloomberg.co.jp/news/articles/2023-09-08/S0MZGOT1UM0W01
ãæ¬§å·çŸç äºé²ç®¡çã»ã³ã¿ãŒïŒïŒ¥ïŒ£ïŒ€ïŒ£ïŒã¯ã倧ããå€ç°ããæ°åã³ãããŠã€ã«ã¹ã®æ°ããªå€ç°æ ªãããã©ããæ¬§å·å€§éžã§åºãã£ãŠãããã³ããææè å¢å ã®èæ¯ã«ãããããããªããšèŠåãããã
欧å·ããããŸãããã»ã»ã»ã
ãã¯å£°æã§ãæ£åŒåç§°ãBA.2.86ãã®ãã®å€ç°æ ªã¯ïŒæã«æ£çºçã«ç¢ºèªããããšããæè¿ã®é¡èãªæææ¡å€§ã®èŠå ãšãªã£ãŠããå¯èœæ§ã«èšåãããã
ãããŸã§ãå¯èœæ§ãææããã ãã§ãæç¢ºãªãšããã³ã¹ããããããããªãã
ãã®ã¢ã¢ã³æé·ã¯å£°æã§ãæ°ããªå€ç°æ ªãéçåãã¯ã¯ãã³ã®å¹æäœæžãšé¢é£ããŠãã蚌æ ã¯ãªããšææãããã
ããåœå±ããããã©ãå±±è»ã«ããŠãã¯ã¯ãã³æ¥çš®ãææå¯Ÿçãæšé²ããããšããŠããããšã¯æçœã ãªã
ãååçã§ç§ãšå¬ãè¿ã¥ãäžã§ã欧å·ãªã©ã®åœå±ã¯ååœã«å¯Ÿããéçåãªã¹ã¯ã®ãã人ãäžå¿ã«ã¯ã¯ãã³æ¥çš®ãé²ããåãçµã¿ã®åŒ·åãåŒã³ãããŠãããã
åã¯ã¯ãã³ãã£ã³ããŒã³ãå±éããŠãããã¹ã³ãããã©ãåå¿ããããèŠãã®ã ã
æãåœã®æ¿åºã¯ãåŸæ¥ãïŒå²ä»¥äžãæ¥çš®ããŠããé«éœ¢è ã®å šæ°ã«ãæºããªã調éãããããŠããªãã
ã€ãŸããå šãããæ°ããªãããšãæåãã倧ã£ãŽãã«ããŠããããã ã
ãã¡ããã远å 調éãããããšãåæãšããåå調éãšãããšã¯ã¹ãã¥ãŒãºã¯ãããã©ãæ¥çš®å¯Ÿè±¡ã¯ïŒå人以äžã ãããªïŒèª¿éæ°ã¯ïŒïŒïŒïŒäžïŒã
ç±³åœã欧å·ããã©ãçšã®èª¿éãæããŠããã®ãã¯ç¥ããªãã
æµ®æ²åã¯ã以åããèªç¶ææã«ããå ç«ç²åŸãåæãšããæ¿çã ãšéé£ããŠãããã©ãå šäžççã«ããããåŸåã«ããã®ãããããªãã
ã¯ã¯ãã³ãå¹ããªãããã§ã¯ãªãããã©ããã£ããããšãã£ãŠçœ¹æ£ããªããšããããã§ããªãã
ææäºé²å¹æãçºçäºé²å¹æã¯ããã£ãŠã極å ãã§ãéçåäºé²å¹æã«ããŠããçµæçæžåŒ±ãæ¿ãããæã£ãŠå幎ããããæåŸ ãããããªãé«éœ¢è ã«è³ã£ãŠã¯ãïŒãæããããšããã ããïŒæªç¢ºèªïŒéçåäºé²å¹æã«ã€ããŠã¯ã幎霢éå±€å¥ã®å·®ã¯ãªããšãã話ãïŒã
ãããªã¯ã¯ãã³ã§ãããªãããã¯ãã·ã ã
ããã©ãå±±è»ã«äœ¿ãæã¯ãã©ããåãã ã
ã€ãŒãã䜿ãããã®ã¯äœã§ã䜿ãã
è³ãçºéãããåç©ãšããŠã¯ãæ å ±ã«ãã£ãŠè¡åãå€å®¹ãããªããã°å€±æ Œã ãããªã»ã»ã»ã
ïŒãŸã远å ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒã³ããã¯ã¯ãã³ãåœè²»ã§ã®ç¡ææ¥çš®çµäºãžã65æ³æªæºã¯ååèªå·±è² æ ïŒ
https://mainichi.jp/articles/20230907/k00/00m/100/298000c
ã65æ³ä»¥äžã®é«éœ¢è ãªã©éçåãªã¹ã¯ãé«ã人ã®å Žåãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãšåãã§ãè²»çšã®äžéšãåœã®äº€ä»éã§ãŸããªãã宿æ¥çš®ãã«äœçœ®ã¥ããç§å¬ã«1å宿œããæ¹åã§èª¿æŽããŠãããã
ã¯ã¯ããããã§ç¬¬ïŒæ³¢ãããªãã£ãŠèšã£ãŠãã®ããã»ã»ã»ã
ãããã®è«çã¯éçšããªãã ãããªã
ç¬¬ïŒæ³¢ãè¶ ããèŠæš¡ã§æµè¡ããæ»è ãçžåœæ°åºãŠããã«éããªãã
ã¯ã¯ãã³ãšããã®ã¯ãæµè¡ã«å ç«ã£ãŠæ¥çš®ããæµè¡ãã®ãã®ãæããããšã«ãã£ãŠãææãçºçãéçåãäºé²ããããã®ããã ã
æãããªå€å£ã®æµè¡ãèªããããã«ãããããããã¯ã¯ãã³æ¥çš®ãããªãçç±ãã©ã説æããã€ãããªã®ãã
ãšããã³ã¹ã«åºã¥ãæ¿çã§ã¯ãªããè¡æ¿çéœåã§ããããŒã«ã§ã£ã¡äžããŠãäžžã蟌ãããšããŠããã
ãŸãããã
æãåœã¯ç±åž¯åãã€ã€ãããããªã
ãã®ãã¡ãã€ã³ãã«ãå€å£ã«æµè¡ããããã«ãªããããããªãïŒãããªã®ããïŒïŒïŒãŸããŸã远å ïŒåç §ïŒã
ãããªãã°ã幎ïŒåã®ã¯ã¯ãã³æ¥çš®ãšããã®ãåžžæ ã«ãªãå¯èœæ§ãããã
éçåäºé²ã®èгç¹ãããã幎ïŒåãšããã®ã¯é£ããã ããã
çµæçæžåŒ±ãæ¿ããæ°åã³ããã¯ã¯ãã³ã®å Žåãå¬å£ã ãã§ãæã€ãã©ãããæªãããããã ã
æµ®æ²åã¯ã仿ãã€ãã©ããããã幎å ãããããå¹ãç®ã¯ãªããšèŠãŠããã
æ¥å¹Žã«ãªã£ããããã³ãã³çœ¹æ£ãããããªã
ããããã»ã»ã»ã
ä»æã®æµè¡ã§ã眹æ£ããã«æžããšã¯æããªãã
幎æ«ä»¥éã¯æãåãåŒãç± ãäºå®ã ãã©ãæµè¡ç¶æ³ã«ãã£ãŠã¯é¿ããããªãã ããã
ïŒã·ãŒãºã³ãæããªãã¯ã¯ãã³ããã£ãŠãããŠãããã§å¹ŽéåŒã£åŒµãããšããã®ã¯ç¡çãããã
æµè¡ãæããããšããæ°ã¯ãããããªããããã£ããã©ãããã€ãããªãã ãããã
ãã£ã±ãèªç¶ææããŠãããšããã®ãæ¬é³ã ãšæããããåŸãªãã
ïŒïŒïŒïŒäžä»¶ããã¯ã¯ãã³èª¿éããªãã§ãããèšããã»ã»ã»ã
ïŒãŸããŸã远å ïŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ
ïŒã€ã³ãã«ãšã³ã¶ã®æµè¡ç¶ããåæããæ¬¡ã®ã·ãŒãºã³å ¥ãã¯99幎以éåïŒ
https://news.yahoo.co.jp/articles/074e04f59c832fda0d10680ec7eff2c56460280b
ãå šåœçŽ5åã«æã®å®ç¹å»çæ©é¢ããå ±åãããææ°1é±éïŒ8æ28æ¥ïœ9æ3æ¥ïŒã®å£ç¯æ§ã€ã³ãã«ãšã³ã¶ã®æ£è æ°ãã1å»çæ©é¢ãããã2ã»56人ïŒéå ±å€ïŒãã ã£ããã1人ããè¶ ããšãæµè¡ããšãããæšå¹Ž12æ19ïœ25æ¥ã«æµè¡æå ¥ãããããšããããŸã§äžåºŠãäžåã£ãŠããªããã
ãæµè¡ãåæããªããŸãŸæ¬¡ã®ã·ãŒãºã³ã«çªå ¥ããã®ã¯ãçŸåšã®æ¹æ³ã«ãªã£ã1999幎以æ¥ãåããŠãšãããã
ããããã»ã»ã»ã
ãæµè¡ãç¶ããŠããèæ¯ãšããŠã3幎éã€ã³ãã«ã®æµè¡ããªãã£ãããšããæšå¹Žã®ã¯ã¯ãã³æ¥çš®ããæéããã£ãããšã§ã1äººãææãããšåšå²ã«åºãããããç¶æ³ããããšææããããŸããæ°åã³ããã®5é¡ç§»è¡ã§ææå¯Ÿçãç·©ãã ããšããããšãããã
äœããç®ã«èŠããªããšããã§ãéãã«å€§ããå€ãã£ãŠããããšããããã ããã
ææçã®æµè¡ãå ç«ã®äœäžã¯ããã®å€§ããªåãã衚é¢åããäžéšåãªã®ã«éããªãã
æãåœã®ããã«ãå¹³åã§éç©ãªç¶æ³ã§ãªããã°ããã®ä»ã®ãã€ãºã«ããæ¶ãããŠããŸãçšåºŠã®åŸ®åŠãªå€åã
å人ã®ã¬ãã«ã§ã¯ããªããšãªããã€ããšéãçšåºŠã«ããæããããªãããããããã®éãã
ãã£ã±ãå°ç£æ°ç°åžžãšããç°æäººã®æ»æãšãããããªãã¯ã¹ã®ãã°ãšããããããã¯ã±ã¯ã«ãªè©±ã«ãªããã ãããïŒïŒããã¯ããã§ãå«ããããªããã§ããã©ïŒã
ïŒå°ç£æ°ã¯äººäœã«åœ±é¿ããŸããïŒïŒ
https://www.isee.nagoya-u.ac.jp/50naze/chijiki/46.html
ãæ±æŽå»åŠã§ã¯ãç£æ°ãå¥åº·ã«åœ±é¿ãåãŒããæ°ãã®äžçš®ãšã¿ãªãããŠããŸãã ããããèªç¶ç§åŠã®ç«å Žããèšãã°ãå°ç£æ°ã人ã®å¥åº·ã«çŽæ¥åœ±é¿ããããšã¯ãªããšèããããŸãã ãã®ããšã¯ãå°ç£æ°ã人ãå«ãçåœã®å¥åº·ç¶æ ãšç¡é¢ä¿ã§ãããšããæå³ã§ã¯ãããŸãããã
ããŒããçŠ åçã®ãããªåçã ãªã
ãäŸãã°ãå°ç£æ°ã匱ããªãã°å®å®è¹ã®ç §å°ãå¢ãã人ã®å¥åº·ã«ç倧ãªåœ±é¿ãåãŒãããšã«ãªããšäºæ³ãããŸãã
ã€ãŸãããçŽæ¥çãªåœ±é¿ãã¯ãªããã©ãã鿥çãªåœ±é¿ãã¯ãããšããããšãã
ïŒïŒïŒïŒå¹Žå®å®ã®åºŠã§ã¯ããã³ã¯ã¬ãŒã¿ãŒã®å°ç£æ°ç°åžžãããã¢ããªã¹ãçºèŠããŠããŸããšããçæžãã ã£ãèšæ¶ãããã
ïŒã¢ããªã¹(2001幎å®å®ã®æ )ïŒ
https://dic.pixiv.net/a/%E3%83%A2%E3%83%8E%E3%83%AA%E3%82%B9%282001%E5%B9%B4%E5%AE%87%E5%AE%99%E3%81%AE%E6%97%85%29
ãTMA-1
æé¢ã®ãã³ã¯ã¬ãŒã¿ãŒä»è¿ã§çºèŠãããç£æ°ç°åžžã®æ£äœããã³ç£æ°ç°åžžïŒTycho Magnetic AnomalyïŒããšããŠãæã®å°äžããçºæãããç©äœãã
ãŸããã©ãã§ããããã§ããã
ïŒå°ç£æ°ïŒå°ç£æ°ã®å€åã®å°çç°å¢ãžã®åœ±é¿ïŒ
https://ja.wikipedia.org/wiki/%E5%9C%B0%E7%A3%81%E6%B0%97#%E5%9C%B0%E7%A3%81%E6%B0%97%E3%81%AE%E5%A4%89%E5%8B%95%E3%81%AE%E5%9C%B0%E7%90%83%E7%92%B0%E5%A2%83%E3%81%B8%E3%81%AE%E5%BD%B1%E9%9F%BF
ãå°ç£æ°ã匱ãŸãäºã«ããã倧æ°åå ãžã®å®å®ç·ã®å ¥å°éãå¢å€§ããããšã«ããã倧æ°äžã®éå·åŽæ°Žèžæ°ãå®å®ç·ã®é£è·¡ãæ žãšããŠåçµãããããé²ã®éãå¢å ããŠæ¥å°éã«åœ±é¿ãäžããããŸããå°è¡šã«å°éããå®å®ç·ã®å¢å ã«ãããçç©ã®ããªãã·ãªãæ žé žãæå·ãã確çãé«ãŸããããçªç¶å€ç°ã®å¢å ããäžå ãšãèãããããã
ããããå°ç£æ°å転ããããã®ã§ã¯ãªãããšããå°ç£æ°ã®æžåŒ±ãç¶ããŠãããšããã話ã¯ããèãã
ãé¢é£ããæ åäœåïŒ
ããã¥ã¡ã³ã¿ãªãŒããµã€ãšã³ã¹ã»ã¯ãŒã«ããã·ãªãŒãº 第6åãå°çã®èŠãããçŸãïŒãã·ã§ãã«ã»ãžãªã°ã©ãã£ãã¯ïŒã
é²ç»ããŠãäœåºŠãèŠè¿ããŠãããã ããã ãã¶æŽè³ããã¡ãŸã£ãŠãã®ãããããªãã
ãããã«ããŠããä»å¹Žã®å€ã®æãã¯ç°åžžã ã£ãã
å ç«ãäœäžãããããã¯ãæ³å®ã®ç¯å²å ã ãããªã»ã»ã»ã

ã³ã¡ã³ããã©ãã
â»ã¡ãŒã«ã¢ãã¬ã¹ãšURLã®å ¥åã¯å¿ é ã§ã¯ãããŸããã å ¥åãããã¡ãŒã«ã¢ãã¬ã¹ã¯èšäºã«åæ ããããããã°ã®ç®¡çè ã®ã¿ãåç §ã§ããŸãã
â»ãªããéãããã³ã¡ã³ãã¯ããã°ã®ç®¡çè ã確èªãããŸã§å ¬éãããŸããã
â»æçš¿ã«ã¯ç®¡çè ãèšå®ãã質åã«çããå¿ èŠããããŸãã